Dysregulation of the Retromer Complex in Brain Endothelial Cells Results in Accumulation of Phosphorylated Tau

References

• Abbott NJ. Blood–brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis. 2013;36:437–449. doi:10.1007/s10545-013-9608-0
   PubMed Web of Science ®Google Scholar
• Engelhardt B. Development of the blood-brain barrier. Cell Tissue Res. 2003;314:119–129. doi:10.1007/s00441-003-0751-z
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Patabendige AAK, Dolman DEM, et al. Structure and function of the blood–brain barrier. Neurobiol Dis. 2010;37(1):13–25. doi:10.1016/j.nbd.2009.07.030
   PubMed Web of Science ®Google Scholar
• Gonzalez-Carter D, Liu X, Tockary TA, et al. Targeting nanoparticles to the brain by exploiting the blood–brain barrier impermeability to selectively label the brain endothelium. Proc Natl Acad Sci USA. 2020;117(32):19141–19150. doi:10.1073/pnas.2002016117
   PubMed Web of Science ®Google Scholar
• Haqqani AS, Delaney CE, Brunette E, et al. Endosomal trafficking regulates receptor-mediated transcytosis of antibodies across the blood brain barrier. J Cereb Blood Flow Metab. 2018;38:727–740. doi:10.1177/0271678X17740031
   PubMed Web of Science ®Google Scholar
• Bell L, Koeniger T, Tacke S, et al. Characterization of blood–brain barrier integrity in a B-cell-dependent mouse model of multiple sclerosis. Histochem Cell Biol. 2019;151(6):489–499. doi:10.1007/s00418-019-01768-6
   PubMed Web of Science ®Google Scholar
• Wu S, Liu H, Zhao H, et al. Environmental lead exposure aggravates the progression of Alzheimer’s disease in mice by targeting on blood brain barrier. Toxicol Lett. 2020;319:138–147. doi:10.1016/j.toxlet.2019.11.009
   PubMed Web of Science ®Google Scholar
• Wang H, Qi W, Zou C, et al. NEK1-mediated retromer trafficking promotes blood–brain barrier integrity by regulating glucose metabolism and RIPK1 activation. Nat Commun. 2021;12:4826. doi:10.1038/s41467-021-25157-7
   PubMed Web of Science ®Google Scholar
• Filippone A, Praticò D. Endosome dysregulation in down syndrome: a potential contributor to Alzheimer disease pathology. Ann Neurol. 2021;90(1):4–14. doi:10.1002/ana.26042
   PubMed Web of Science ®Google Scholar
• Vagnozzi A, Praticò D. Endosomal sorting and trafficking, the retromer complex and neurodegeneration. Mol Psychiatry. 2019;24:857–868. doi:10.1038/s41380-018-0221-3
   PubMed Web of Science ®Google Scholar
• Tang FL, Zhao L, Zhao Y, et al. Coupling of terminal differentiation deficit with neurodegenerative pathology in Vps-35-deficient pyramidal neurons. Cell Death Differ. 2020;27:2099–2116. doi:10.1038/s41418-019-0487-2
   PubMed Web of Science ®Google Scholar
• Toth AE, Nielsen SSE, Tomaka W, et al. The endo-lysosomal system of Bend.3 and hCMEC/D3 brain endothelial cells. Fluids Barriers CNS. 2019;16(1):14. doi:10.1186/s12987-019-0134-9
   PubMedGoogle Scholar
• Weksler B, Romero IA, Couraud PO. The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS. 2013;10(1):16. doi:10.1186/2045-8118-10-16
   PubMedGoogle Scholar
• Li JG, Chiu J, Praticò D. Full recovery of the Alzheimer’s disease phenotype by gain of function of vacuolar protein sorting 35. Mol Psychiatry. 2020;25(10):2630–2640. doi:10.1038/s41380-019-0364-x
   PubMed Web of Science ®Google Scholar
• Vagnozzi AN, Li JG, Chiu J, et al. VPS35 regulates tau phosphorylation and neuropathology in tauopathy. Mol Psychiatry. 2019. doi:10.1038/s41380-019-0453-x
   Web of Science ®Google Scholar
• Ekyune K, Lee Y, Lee H, et al. Implication of mouse Vps26b–Vps29–Vps35 retromer complex in sortilin trafficking. Biochem Biophys Res Commun. 2010. doi:10.1016/j.bbrc.2010.10.121
   Web of Science ®Google Scholar
• Filippone A, Li JG, Pratico’ D. VPS35 downregulation alters degradation pathways in neuronal cells. J Alzheimers Dis. 2021;84(3):1079–1089. doi:10.3233/JAD-210701
   PubMed Web of Science ®Google Scholar
• Yoshii SR, Mizushima N. Monitoring and measuring autophagy. Int J Mol Sci. 2017;18(9):1865. doi:10.3390/ijms18091865
   PubMed Web of Science ®Google Scholar
• Fuse A, Furuya N, Kakuta S, et al. VPS29-VPS35 intermediate of retromer is stable and may be involved in the retromer complex assembly process. FEBS Lett. 2015;589:1430–1436. doi:10.1016/j.febslet.2015.04.040
   PubMed Web of Science ®Google Scholar
• Pekol T, Daniels JS, Labutti J, et al. Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites. Drug Metab Dispos. 2005;33(6):771–777. doi:10.1124/dmd.104.002956
   PubMed Web of Science ®Google Scholar
• Colacurcio DJ, Nixon RA. Disorders of lysosomal acidification. The emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res Rev. 2016;32:75–88. doi:10.1016/j.arr.2016.05.004
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Tagawa Y, Yoshimori T, et al. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct. 1998;23:33–42. doi:10.1247/csf.23.33
   PubMed Web of Science ®Google Scholar
• Polanco JC, Hand GR, Briner A, et al. Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol. Acta Neuropathol. 2021;141(2):235–256. doi:10.1007/s00401-020-02254-3
   PubMed Web of Science ®Google Scholar
• Maruzs T, Lőrincz P, Szatmári Z, et al. Retromer ensures the degradation of autophagic cargo by maintaining lysosome function in drosophila. Traffic. 2015;16(10):1088–1107. doi:10.1111/tra.12309
   PubMed Web of Science ®Google Scholar
• Lőrincz P, Lakatos Z, Maruzs T, et al. Atg6/UVRAG/Vps34-containing lipid kinase complex is required for receptor downregulation through endolysosomal degradation and epithelial polarity during drosophila wing development. BioMed Res Int. 2014;2014:851349. doi:10.1155/2014/851349
   PubMed Web of Science ®Google Scholar
• Falk MM, Fong JT, Kells RM, et al. Degradation of endocytosed gap junctions by autophagosomal and endo-/lysosomal pathways: a perspective. J Membr Biol. 2012;245(8):465–476. doi:10.1007/s00232-012-9464-0
   PubMed Web of Science ®Google Scholar
• Zhao YG, Codogno P, Zhang H. Machinery, regulation and pathophysiological implications of autophagosome maturation. Nat Rev Mol Cell Biol. 2021;1–18. doi:10.1038/s41580-021-00392-4
   PubMed Web of Science ®Google Scholar
• Weksler BB, Subileau EA, Perriere N, et al. Blood–brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 2005;19:1872–1874. doi:10.1096/fj.04-3458fje
   PubMed Web of Science ®Google Scholar
• Predescu SA, Predescu DN, Malik AB. Molecular determinants of endothelial transcytosis and their role in endothelial permeability. Am J Physiol Lung Cell Mol Physiol. 2007;293:L823–L842. pmid: 17644753. doi:10.1152/ajplung.00436.2006
   PubMed Web of Science ®Google Scholar
• Sager KL, Wuu J, Herskowitz JH, et al. Neuronal LR11 expression does not differentiate between clinically defined Alzheimer’s disease and control brains. PLoS One. 2012;7(8):e40527. doi:10.1371/journal.pone.0040527
   PubMed Web of Science ®Google Scholar
• Li Y, Rowland C, Catanese J, et al. SORL1 variants and risk of late-onset Alzheimer’s disease. Neurobiol Dis. 2008;29(2):293–296. doi:10.1016/j.nbd.2007.09.001
   PubMed Web of Science ®Google Scholar
• Chung KM, Hernández N, Sproul AA, Yu WH. Alzheimer’s disease and the autophagic-lysosomal system. Neurosci Lett. 2019;697:49–58. doi:10.1016/j.neulet.2018.05.017
   PubMed Web of Science ®Google Scholar
• Hartz A, Zhong Y, Wolf A, et al. Aβ40 reduces P-glycoprotein at the blood–brain barrier through the ubiquitin–proteasome pathway. J Neurosci. 2016;36(6):1930–1941. doi:10.1523/JNEUROSCI.0350-15.2016
   PubMedGoogle Scholar
• Jucker M, Walker L. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature. 2013;501(7465):45–51. doi:10.1038/nature12481
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2021;17(1):1–382.
   PubMed Web of Science ®Google Scholar
• Carosi JM, Hein L, Hurk M, et al. Retromer regulates the lysosomal clearance of MAPT/tau. Autophagy. 2020. doi:10.1080/15548627.2020.1821545
   Web of Science ®Google Scholar
• Chen X, Kordich J, Williams E, et al. Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration. Proc Natl Acad Sci USA. 2019;116(12):5765–5774. doi:10.1073/pnas.1814909116
   PubMed Web of Science ®Google Scholar
• Gao L, Xiao H, Ai L, et al. Vps35 deficiency impairs cdk5/p35 degradation and promotes the hyperphosphorylation of tau protein in retinal ganglion cells. Invest Ophthalmol Vis Sci. 2020;61(1):1. doi:10.1167/iovs.61.1.1
   Web of Science ®Google Scholar
• Vitale F, Giliberto L, Ruiz S, et al. Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice. Acta Neuropathol Commun. 2018;6(1):82. doi:10.1186/s40478-018-0585-2
   PubMedGoogle Scholar
• Inoue Y, Ando Y, Misumi Y, Ueda M. Current management and therapeutic strategies for cerebral amyloid angiopathy. Int J Mol Sci. 2021;22(8):3869. doi:10.3390/ijms22083869
   PubMed Web of Science ®Google Scholar